Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective

Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study

(2018) Si Si et al.   Heart Lung and Circulation

The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective

(2018) Radya Kumar et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective

(2018) Zanfina Ademi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease

(2018) Sonia S. Anand et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

(2018) Sonia S Anand et al.   LANCET

Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test

(2018) Nathan K Itoga et al.   VASCULAR MEDICINE

Peripheral arterial disease: Changes in clinical outcomes and therapeutic strategies in two cohorts, from 2002 to 2008 and from 2008 to 2014. A population-based study

(2018) Marta Baviera et al.   European Journal of Preventive Cardiology

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK

(2017) Lucía Cea Soriano et al.   European Journal of Preventive Cardiology

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation

(2016) Jan Beyer-Westendorf et al.   EUROPACE

Clopidogrel Versus Aspirin in Patients with Recent Ischemic Stroke and Established Peripheral Artery Disease: An Economic Evaluation in a Chinese Setting

(2015) Te Li et al.   CLINICAL DRUG INVESTIGATION

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure

(2015) Colleen A. McHorney et al.   CURRENT MEDICAL RESEARCH AND OPINION

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

(2014) Mark R. Nehler et al.   JOURNAL OF VASCULAR SURGERY

Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation

(2014) Alexander Mensch et al.   PHARMACOECONOMICS

Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction

(2014) Eldrin F. Lewis et al.   JACC-Heart Failure

New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis

(2013) I. Lisanne Holster et al.   GASTROENTEROLOGY

Outcomes and Excess Costs among Patients with Cardiovascular Disease

(2013) Zanfina Ademi et al.   Heart Lung and Circulation

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

(2013) Amanda R. Harrington et al.   STROKE

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective

(2013) Craig D. Seaman et al.   THROMBOSIS RESEARCH

Clopidogrel versus Aspirin in Patients with Atherothrombosis

(2013) Georgia Kourlaba et al.   Applied Health Economics and Health Policy

Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

(2012) Linda J Cobiac et al.   BMC PUBLIC HEALTH

Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis

(2012) et al.   MEDICAL JOURNAL OF AUSTRALIA

Population Trends of Recurrent Coronary Heart Disease Event Rates Remain High

(2010) Tom G. Briffa et al.  

Quality of Life of Persons With Lower-Limb Amputation During Rehabilitation and at 3-Month Follow-Up

(2009) Diana Zidarov et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION